Drug To Stop Migraine Before Onset? Study Says 73% Could Restore Normal Functioning

Within two hours of taking the medication, those who took ubrogepant were 73% more likely to report "no disability, able to function normally" compared to those who took the placebo. (Credit: Image by Yanalya on Freepik)

A drug, when administered at the first signs of migraine, may help curb the onset of headache in patients prone to the migraine attack, allowing them to continue their daily activities with little or no symptoms, a recent trial reveals.

When taken at the onset of symptoms like sensitivity to light and sound, fatigue, neck pain, or dizziness, Ubrogepant helped 73% of migraine patients regain normal function, according to the study results published in the journal Neurology.